Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 12-2018 | 09-2010 | 06-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -81,199 | -49,858 | -123,096 | 78,500 | 66,900 |
| Depreciation Amortization | 1,149 | 795 | 740 | 63,800 | 48,100 |
| Income taxes - deferred | N/A | N/A | N/A | -300 | -200 |
| Accounts receivable | 42 | 182 | N/A | -56,100 | -32,300 |
| Accounts payable and accrued liabilities | -1,741 | -5,579 | N/A | 14,700 | 600 |
| Other Working Capital | -8,885 | -7,108 | 481 | -25,200 | -35,200 |
| Other Operating Activity | 2,708 | 5,880 | 513 | 61,200 | 54,300 |
| Operating Cash Flow | $-87,926 | $-55,688 | $-121,362 | $136,600 | $102,200 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -189 | -150 | -944 | -28,100 | -21,500 |
| Net Acquisitions | N/A | N/A | 0 | 7,300 | 11,300 |
| Purchase Of Investment | N/A | N/A | N/A | -217,200 | -215,300 |
| Sale Of Investment | N/A | N/A | N/A | 68,500 | 27,100 |
| Purchase Sale Intangibles | -1,765 | -1,757 | N/A | N/A | N/A |
| Other Investing Activity | -1,765 | -1,757 | -1,562 | 17,000 | 16,300 |
| Investing Cash Flow | $-1,954 | $-1,907 | $-2,506 | $-152,500 | $-182,100 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -700 | -500 |
| Common Stock Issued | 101,614 | 74,838 | N/A | N/A | N/A |
| Common Stock Repurchased | -141 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -832 | 26,093 | -24 | -1,600 | -1,600 |
| Financing Cash Flow | $100,641 | $100,931 | $-24 | $-2,300 | $-2,100 |
| Exchange Rate Effect | -51 | 13 | -53 | 800 | -4,300 |
| Beginning Cash Position | 138,807 | 138,807 | 262,752 | 535,500 | 535,500 |
| End Cash Position | 149,517 | 182,156 | 138,807 | 518,100 | 449,200 |
| Net Cash Flow | $10,710 | $43,349 | $-123,945 | $-17,400 | $-86,300 |
| Free Cash Flow | |||||
| Operating Cash Flow | -87,926 | -55,688 | -121,362 | 136,600 | 102,200 |
| Capital Expenditure | -189 | -150 | N/A | -29,400 | -21,800 |
| Free Cash Flow | -88,115 | -55,838 | -121,362 | 107,200 | 80,400 |